https://www.adelaide.edu.au/ics/ en https://www.adelaide.edu.au/ics/news/list/2024/12/03/developing-the-first-drug-for-multi-organ-radiation-protection A pharmaceutical breakthrough at the University of Adelaide is showing promise in both multi-organ radiation protection and cancer treatment. December 03 2024 Leah Panakera-Thorpe https://www.adelaide.edu.au/ics/news/list/2024/12/03/developing-the-first-drug-for-multi-organ-radiation-protection https://www.adelaide.edu.au/ics/news/list/2020/04/20/partnership-to-revolutionise-cancer-diagnostic The University of Adelaide has partnered with medical technology company Sienna Cancer Diagnostics in an exclusive worldwide licence agreement to develop a unique cancer probe with the potential to detect a sugar molecule only present in cancer cells. April 20 2020 Rebecca Jane Farrell https://www.adelaide.edu.au/ics/news/list/2020/04/20/partnership-to-revolutionise-cancer-diagnostic